List of Elucid Bioimaging Inc. patents

Patents where

Current Assignee

Name

Elucid Bioimaging Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10176408 Systems and methods for analyzing pathologies utilizing quantitative imaging	Patent 10176408 was granted and assigned to Elucid Bioimaging Inc. on January, 2019 by the United States Patent and Trademark Office.		Elucid Bioimaging Inc.	United States Patent and Trademark Office	10176408	January 8, 2019
‌ US Patent 11087460 Methods and systems for training and validating quantitative imaging biomarkers	Patent 11087460 was granted and assigned to Elucid Bioimaging Inc. on August, 2021 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11087460	August 10, 2021
‌ US Patent 11607179 Non-invasive risk stratification for atherosclerosis	Patent 11607179 was granted and assigned to Elucid Bioimaging Inc. on March, 2023 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11607179	March 21, 2023
‌ US Patent 11087459 Quantitative imaging for fractional flow reserve (FFR)	Patent 11087459 was granted and assigned to Elucid Bioimaging Inc. on August, 2021 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11087459	August 10, 2021
‌ US Patent 11113812 Quantitative imaging for detecting vulnerable plaque	Patent 11113812 was granted and assigned to Elucid Bioimaging Inc. on September, 2021 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11113812	September 7, 2021
‌ US Patent 11676359 Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology	Patent 11676359 was granted and assigned to Elucid Bioimaging Inc. on June, 2023 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11676359	June 13, 2023
‌ US Patent 11696735 Quantitative imaging for instantaneous wave-free ratio	Patent 11696735 was granted and assigned to Elucid Bioimaging Inc. on July, 2023 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11696735	July 11, 2023
‌ US Patent 11120312 Quantitative imaging for cancer subtype	Patent 11120312 was granted and assigned to Elucid Bioimaging Inc. on September, 2021 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11120312	September 14, 2021
‌ US Patent 11094058 Systems and method for computer-aided phenotyping (CAP) using radiologic images	Patent 11094058 was granted and assigned to Elucid Bioimaging Inc. on August, 2021 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11094058	August 17, 2021
‌ US Patent 12106477 Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy	Patent 12106477 was granted and assigned to Elucid Bioimaging Inc. on October, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	12106477	October 1, 2024
‌ US Patent 11508063 Non-invasive measurement of fibrous cap thickness	Patent 11508063 was granted and assigned to Elucid Bioimaging Inc. on November, 2022 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11508063	November 22, 2022
‌ US Patent 11257584 Quantitative medical imaging reporting	Patent 11257584 was granted and assigned to Elucid Bioimaging Inc. on February, 2022 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11257584	February 22, 2022
‌ US Patent 12125572 Determining likely response to anti-inflammatory and pro-resolving therapies for cardiovascular disease non-invasively	Patent 12125572 was granted and assigned to Elucid Bioimaging Inc. on October, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	12125572	October 22, 2024
‌ US Patent 11887701 Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease	Patent 11887701 was granted and assigned to Elucid Bioimaging Inc. on January, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11887701	January 30, 2024
‌ US Patent 11887713 Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease	Patent 11887713 was granted and assigned to Elucid Bioimaging Inc. on January, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11887713	January 30, 2024
‌ US Patent 11869186 Non-invasive determination of likely response to combination therapies for cardiovascular disease	Patent 11869186 was granted and assigned to Elucid Bioimaging Inc. on January, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11869186	January 9, 2024
‌ US Patent 11657486 Systems and methods for improving soft tissue contrast, multiscale modeling and spectral CT	Patent 11657486 was granted and assigned to Elucid Bioimaging Inc. on May, 2023 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11657486	May 23, 2023
‌ US Patent 11593926 Systems and methods for improving soft tissue contrast, multiscale modeling and spectral CT	Patent 11593926 was granted and assigned to Elucid Bioimaging Inc. on February, 2023 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11593926	February 28, 2023
‌ US Patent 11887734 Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease	Patent 11887734 was granted and assigned to Elucid Bioimaging Inc. on January, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11887734	January 30, 2024
‌ US Patent 10755810 Methods and systems for representing, storing, and accessing computable medical imaging-derived quantities	Patent 10755810 was granted and assigned to Elucid Bioimaging Inc. on August, 2020 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	10755810	August 25, 2020
‌ US Patent 10740880 Systems and methods for analyzing pathologies utilizing quantitative imaging	Patent 10740880 was granted and assigned to Elucid Bioimaging Inc. on August, 2020 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	10740880	August 11, 2020
‌ US Patent 11715187 Extended tissue types for increased granularity in cardiovascular disease phenotyping		Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11715187	August 1, 2023
‌ US Patent 11791027 Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease	Patent 11791027 was granted and assigned to Elucid Bioimaging Inc. on October, 2023 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	11791027	October 17, 2023
‌ US Patent 12125571 Determining likely response to glycemic treatment for cardiovascular disease non-invasively	Patent 12125571 was granted and assigned to Elucid Bioimaging Inc. on October, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	12125571	October 22, 2024
‌ US Patent 12118694 Progressive exploitation of multi-energy and photon counting modalities	Patent 12118694 was granted and assigned to Elucid Bioimaging Inc. on October, 2024 by the United States Patent and Trademark Office.	Elucid Bioimaging Inc.	Elucid Bioimaging Inc.	United States Patent and Trademark Office	12118694	October 15, 2024

Results per page:

31 results

0 selected

31 results

0 selected